AES
57
13
CAT
76
2
UAL
77
-8
HSY
37
2
HPE
45
7
VRTX
53
-3
AME
63
-2
LUV
62
-9
RL
76
-2
IBM
67
3
SLG
30
-14
ESS
39
-5
ES
45
5
EW
60
7
CAG
34
-3
XOM
60
-2
NDAQ
67
5
GRMN
45
3
CF
48
3
ADP
61
-3
AES
57
13
CAT
76
2
UAL
77
-8
HSY
37
2
HPE
45
7
VRTX
53
-3
AME
63
-2
LUV
62
-9
RL
76
-2
IBM
67
3
SLG
30
-14
ESS
39
-5
ES
45
5
EW
60
7
CAG
34
-3
XOM
60
-2
NDAQ
67
5
GRMN
45
3
CF
48
3
ADP
61
-3
Financhill
Back

Artiva Biotherapeutics, Inc. 10K Form

Buy
67

ARTV
Artiva Biotherapeutics, Inc.

Last Price:
$3.69
Seasonality Move:
-1.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARTV News And Ratings

See the #1 stock for the next 7 days that we like better than ARTV

ARTV Financial Statistics

Sales & Book Value

Annual Sales: $251K
Cash Flow: $-19.8M
Price / Cash Flow: 0
Annual Sales: $5.26
Price / Book: 0.71

Profitability

EPS (TTM): -3.24820
Net Income (TTM): $-79.2M
Gross Margin: $-2.2M
Return on Equity: -47.44%
Return on Assets: -41.91%

Artiva Biotherapeutics, Inc. Earnings Forecast

Key Artiva Biotherapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 4 years for ARTV is -868.53%.
  • The Selling, General & Administrative Expenses for ARTV have been equal to 6,854.58% of Gross Profit Margin.
  • The Research & Development expenses have been 19,082.47% of Revenue.
  • The Net Earning history of ARTV is -26,045.02% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Artiva Biotherapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARTV
Website: artivabio.com

Debt

Debt-to-Equity Ratio: 0.09
Current Ratio: 11.65
Quick Ratio: 11.06

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARTV Technical Analysis vs Fundamental Analysis

Buy
67
Artiva Biotherapeutics, Inc. (ARTV) is a Buy

Is Artiva Biotherapeutics, Inc. a Buy or a Sell?